Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was CNY 593.42 million compared to CNY 473.66 million a year ago. Net income was CNY 104.66 million compared to CNY 96.97 million a year ago. Basic earnings per share from continuing operations was CNY 0.1868 compared to CNY 0.173 a year ago.